Drug Profile
AR 9281
Alternative Names: AR9281Latest Information Update: 06 Aug 2015
Price :
$50
*
At a glance
- Originator Arete Therapeutics
- Class Antihypertensives; Lipids; Small molecules; Vasodilators
- Mechanism of Action Epoxide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypertension; Type 2 diabetes mellitus
Most Recent Events
- 09 Jun 2009 Pharmacokinetics, pharmacodynamics and safety data from preclinical and phase I trials presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA-2009) ,, ,
- 12 Feb 2009 Phase-II clinical trials in Hypertension in USA (PO)
- 12 Feb 2009 Phase-II clinical trials in Type-2 diabetes mellitus in USA (PO)